Clinical trial results have shown further that two GLP-1 receptor agonists (GLP-1 RAs), exenatide and liraglutide, which are approved for the treatment of hyperglycemia in patients with type 2 diabetes, also produce weight loss in overweight subjects without diabetes
Does the relationship between exercise and recovery change on GLP-1s
Shes a compassionate and highly-regarded dentist with her own practice in Washington, Pennsylvania, known for providing modern, comprehensive dental care, botox and facial aesthetics with a focus on patient comfort and anxiety reduction, serving general, cosmetic, and pediatric dentistry needs.
If either agent is used alongside insulin or a sulfonylurea, the risk of hypoglycaemia is increased and medication doses should be reviewed by a clinician